Skip to main content

Umecrine Cognition

Solna, Sweden

Umecrine Cognition is a developer of pharmaceutical products to treat cognitive neurological disorders.

$2.6M raised
Jul 2025
Convertible Note

Top Investors

Almi InvestMichael J. Fox FoundationRibbskottetKarolinskaPartnerinvest Norr

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Umecrine Cognition

How much funding has Umecrine Cognition raised?
Umecrine Cognition has raised $2.6M in total funding. The most recent round was Convertible Note. The last funding was announced in July 2025.
Who are Umecrine Cognition's investors?
Umecrine Cognition's investors include Almi Invest, Michael J. Fox Foundation, Ribbskottet, Karolinska, Partnerinvest Norr.
Where is Umecrine Cognition headquartered?
Umecrine Cognition is headquartered in Solna, Sweden.
What does Umecrine Cognition do?
Umecrine Cognition is a developer of pharmaceutical products to treat cognitive neurological disorders.
What stage is Umecrine Cognition at?
Umecrine Cognition is at the Convertible Note stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Umecrine Cognition — Funding & Investors." VCBacked, July 14, 2025, https://www.vcbacked.co/company/umecrine-cognition. Accessed June 4, 2026.
APA
VCBacked. (2025). Umecrine Cognition — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/umecrine-cognition
Wikipedia (cite web)
{{cite web |title=Umecrine Cognition — Funding & Investors |url=https://www.vcbacked.co/company/umecrine-cognition |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .